Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
XK related, Y-linked pseudogene 3 (XKRYP3) is classified as a pseudogene located on the Y chromosome. Pseudogenes are nonfunctional genomic DNA segments that resemble known genes but typically contain mutations that prevent them from producing functional proteins[1][5][6]. While some pseudogenes can play regulatory roles, such as acting as decoys for microRNAs or sources of non-coding RNA, there is no current evidence indicating that XKRYP3 has any established physiological function, serves as a therapeutic target, or is involved in disease mechanisms[1][3][4][5]. The gene is not associated with any known interacting drugs or used as a biomarker. Its sequence is related to the XK/Kell blood group gene family but has lost coding potential[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on XK related, Y-linked pseudogene 3 (XKRYP3).